Key highlights
12 May 2023 – 1 mins read
LinkedIn
Twitter
Facebook
Understanding the true impact of living with FOP
This year marks the 17th anniversary since the discovery of the ACVR1 gene was announced, a major scientific milestone in fibrodysplasia ossificans progressiva (FOP) research that helped us understand what causes the condition. On April 23, we marked FOP Awareness Day to honor…
Explore more by category
Period
Filter by
recent search
Showing: 1 – 5 of 53 stories
25 October 2024 – 1 mins read
Neuro Connections
At Ipsen, we are invested in helping people who are navigating the challenges of living with debilitating neurological conditions, including those living with the consequences of a stroke.
16 October 2024 – 1 mins read
Addressing the cost of inaction in post-stroke care
At Ipsen, we are invested in helping people who are navigating the challenges of living with debilitating neurological conditions, including those living with the consequences of a stroke.
11 July 2024 – 0 mins read
Financial results for the first half of 2024
Q1 2024 sales announcement will be published on 24 April 2024 at 1pm CET. Find out more and register for the investor and analyst conference call.
28 June 2024 – 0 mins read
24 April 2024 – 0 mins read
Combined Shareholders’ Meeting 2024 (pre announcement page launch)
The Ipsen S.A. Annual General Meeting will be take place on the 28 May 2024, in Paris, France.
Neuro Connections
At Ipsen, we are invested in helping people who are navigating the challenges of living with debilitating neurological conditions, including those living with the consequences of a stroke.
Addressing the cost of inaction in post-stroke care
At Ipsen, we are invested in helping people who are navigating the challenges of living with debilitating neurological conditions, including those living with the consequences of a stroke.
Financial results for the first half of 2024
Q1 2024 sales announcement will be published on 24 April 2024 at 1pm CET. Find out more and register for the investor and analyst conference call.
Combined Shareholders’ Meeting 2024 (pre announcement page launch)
The Ipsen S.A. Annual General Meeting will be take place on the 28 May 2024, in Paris, France.
Together, we can improve the lives of people living with kidney cancer
Together for Kidney Cancer is a global disease awareness initiative funded by Ipsen aiming to raise awareness of the reality of people’s experiences living with kidney cancer and the importance of shared decision making to inform better care outcomes.
Capital Markets Day 2023
Ipsen plans to host a capital-markets day, starting at 12.30 pm GMT on 7 December 2023, at The Brewery, London. In-person attendance is by invitation only. The event will be webcast live.
Ipsen’s partnership with Marengo
Find out more about how we approach partnerships at Ipsen, where every program is a priority within our pipeline. We sat down with Zhen Su, CEO Marengo, to discuss our partnership and how we undertake a one team approach to…
Ipsen’s 2022 Integrated Annual Report now available
2022 was a year of focus, momentum and growth at Ipsen. Learn about the progress we made and download the 2022 Integrated Annual Report here.